Integrichain Blog

Blog

Posts for author: Caitlin Petre

Contracts & Pricing Nick Iaconi Olivia Nweze Victoria Nolan
November 23, 2022

Consumer Price Index, Pricing Transparency Updates, and the Impact of Digital...

5 Minute Read

Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.

Contracts & Pricing Nick Iaconi Brian Bumpus Carter Hall
October 27, 2022

Stacking Discounts for Best Price, PHS & 340B, HHS Ruling

3 Minute Read

Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.

Three Pharma regulatory consultants working at a table

Contracts & Pricing Brian Bumpus Sarah Vo Carter Hall
September 27, 2022

FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice

4 Minute Read

Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.

pharmaceutical pricing strategy reporting

Contracts & Pricing Jeff Baab
August 29, 2022

The Impact of the Inflation Reduction Act on the Pharmaceutical Industry

4 Minute Read

Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.

Contracts & Pricing Olivia Nweze Darren Schneider Michael Gorokhovsky
August 19, 2022

NDC Format Proposal, Focus on PBMs, False Claims Act

4 Minute Read

August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.

Contract Banner

Contracts & Pricing Brian Bumpus Suzaun Shahamat
July 19, 2022

Legal Review: Medicare Program, 340B, and State Price Updates

6 Minute Read

July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.

Corporate Kevin E. Leininger
January 20, 2022

IntegriChain and Blue Fin Group Combine Forces

2 Minute Read

Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.

Events
April 20, 2021

Webinar: INSIGHTS SERIES – Trends in Vaccine and Anti-Viral Drug...

INF Second Read

Events
March 11, 2021

Webinar: Gross-to-Net 2021: An Industry Snapshot

INF Second Read

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper